BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CCMG | CCGM - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CCMG | CCGM
X-ORIGINAL-URL:https://ccmg.51-222-78-205.ygkweb.ca
X-WR-CALDESC:Events for CCMG | CCGM
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241018T110000
DTEND;TZID=America/Toronto:20241018T120000
DTSTAMP:20260626T175756
CREATED:20241017T133247Z
LAST-MODIFIED:20241017T133311Z
UID:10000043-1729249200-1729252800@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nTo register\, click the button below or go to https://us06web.zoom.us/webinar/register/WN_7trryYsQRROjpvFp0VoSHw.  \n \n  \n  \n  \n  \n2024-2025 TeleGraf from 11:00am – 12:00pm ET\, scheduled dates are: \nFriday\, October 18\, 2024 \nTitle: 2SLGBTQI Issues in Medical Genetics Practice \nWe will provide a talk on the provision of equitable health care to individuals within the 2SLGBTQI community with an emphasis on medical genetics. We will define the 2SLGBTQI acronym\, examine challenges and barriers faced by 2SLGBTQI individuals in the community and in health care settings\, demonstrate correct pedigree nomenclature for gender diverse individuals\, and explore case examples specific to the practice of medical genetics. \nSpeakers: \nD’Arcy Prendergast \nD’Arcy Prendergast is a medical genetics and genomics trainee at the University of Toronto currently completing additional subspecialization in prenatal genetics and the care of patients with variations of sexual characteristics. He has given variations of this talk on 2SLGBTQI care with genetic counseling colleagues Ronni Teitelbaum and Carleigh Robertson since 2021 to a variety of MD and GC audiences and is pleased to be able to present this to the TeleGraf audience. \nDr. Prendergast graduated from the Schulich School of Medicine’s Windsor Campus in 2019 and has since been a resident physician in the Medical Genetics and Genomics Residency program at the University of Toronto. His academic interests include the role of geneticists in the care of gender-diverse patients\, the intersection of palliative care and clinical genetics\, and in broader equity and inclusion efforts within the field of genetics. \nDr. Carleigh Robertson \nCarleigh Robertson is a genetic counsellor at the Fred A. Litwin Family Centre in Genetic Medicine at University Health Network\, and an instructor in the MSc Genetic Counselling program within the Temerty Faculty of Medicine at the University of Toronto. She graduated in 2014 from the University of Guelph with a BSc in Molecular Biology and Psychology\, then completed her Master’s of Science in Genetic Counselling at McGill University in 2016. Before relocating to Toronto in 2018\, she provided general genetic counselling services at Health Sciences North in Sudbury\, Ontario and participated in teaching and clinical supervision for trainees at the Northern Ontario School of Medicine. Her research has explored the experiences of transgender individuals in genetic counselling settings and strategies for enhancing medical genetics care for the 2SLGBTQI community. She is certified by the American Board of Genetic Counseling (ABGC). \nDr. Ronni Teitelbaum \nRonni Teitelbaum\, MSc\, CGC\, CCGC received a Master of Science degree in Genetic Counselling from the University of British Columbia in 2002. In 2002\, she was certified in Genetic Counselling by the American Board of Genetic Counseling (ABGC) and the Canadian Association of Genetic Counsellors (CAGC). She is a member of both the ABGC and the CAGC. She is a lecturer and provides clinical supervision to students in the Master of Science degree in Genetic Counselling at the University of Toronto. Ronni has over 20 years of genetic counselling experience in the public healthcare sector in Ontario. She is currently employed as a Genetic Counsellor at Medcan. \nFriday\, November 15\, 2024 \nFriday\, December 20\, 2024 \nFriday\, January 17\, 2025 \nFriday\, February 21\, 2025 \nFriday\, March 21\, 2025 \nFriday\, April 11\, 2025 \nFriday\, May 16\, 2025 \nFriday\, June 20\, 2025
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-2-2/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240927T120000
DTEND;TZID=America/Toronto:20240927T130000
DTSTAMP:20260626T175756
CREATED:20240923T165618Z
LAST-MODIFIED:20240923T165634Z
UID:10000053-1727438400-1727442000@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nTo register\, click the button below or go to https://us06web.zoom.us/webinar/register/WN_MzE5qgCSQCyPI-X9Ys7_IQ  \n \n  \n  \n  \n  \n2024-2025 Leading Strand from 12:00pm – 1:00pm ET\, scheduled dates are: \nFriday September 27\, 2024\nTitle: Standardizing Genome Editing for Rare Disease\nLearning objectives: \n\nIdentify editing strategies for rare diseases.\nDistinguish editing platforms.\n\nSpeaker: Dr. Mark Osborn \nBio: Dr. Mark Osborn is an Associate Professor at the University of Minnesota\, Department of Pediatrics. Dr. Osborn works at the Division of Blood and Marrow Transplant & Cellular & Gene Therapy Center for Genome Engineering. \n  \nFriday October 25\, 2024 \nFriday November 22\, 2024 \nFriday December 13\, 2024 \nFriday\, January 31\, 2025 \nFriday February 28\, 2025 \nFriday\, March 28\, 2025 \nFriday\, April 25\, 2025 \nFriday\, May 30\, 2025 \nFriday June 27\, 2025 \nFriday\, May 16\, 2025 \nFriday\, June 20\, 2025
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-3-2/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240628T120000
DTEND;TZID=America/Toronto:20240628T130000
DTSTAMP:20260626T175756
CREATED:20230927T144256Z
LAST-MODIFIED:20240626T165750Z
UID:10000040-1719576000-1719579600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nNew \nAs of March 2024\, the Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada. \nNote\, to obtain credit for this CPD activity\, you must keep track of the seminars attended.  An easy way to do this is to download and save the certificate for each seminar attended which is available through the evaluation link sent after the seminar to attendees.  A letter at the end of the year will NOT be sent. \n \n  \n  \nAdvancing Clinical Genetics Education in Canada: Current Practices and Emerging Needs \nSpeaker: Dr. Hanna Faghfoury \nBio \nDr. Hanna Faghfoury is a clinical and metabolic geneticist at Mount Sinai Hospital and University Health Network in Toronto as well as an Associate Professor and clinician teacher at the University of Toronto. She has led numerous roles within undergraduate and postgraduate genetics education at Sickkids and at the University of Toronto\, and currently directs the Medical Genetics and Genomics residency program and the Canadian College of Medical Geneticist (CCMG) fellowship programs in both Clinical genetics and Biochemical genetics. Most recently\, she was appointed Expert lead in Inherited Metabolic Disorders at Ontario Health where her team aims to enhance access to care for patients and families with inherited metabolic conditions.  \nFriday\, September 29\, 2023\nFriday\, October 27\, 2023\nFriday\, November 24\, 2023\nFriday\, December 15\, 2023 @ 12:30pm – 1:30pm ET\nFriday\, January 26\, 2024\nFriday\, February 23\, 2024\nFriday\, March 22\, 2024\nFriday\, April 26\, 2024\nFriday\, May 31\, 2024\nFriday\, June 28\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-2024-06-28/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240621T110000
DTEND;TZID=America/Toronto:20240621T120000
DTSTAMP:20260626T175756
CREATED:20230927T144938Z
LAST-MODIFIED:20240617T190848Z
UID:10000024-1718967600-1718971200@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \n \n  \n  \nBeyond Diagnostic Yield: Clinical and Ethical Implications of Implementation of Genomic Technologies in Practice \nThis presentation will discuss a range of clinical and ethical implications of the implementation of genomic technologies in practice\, beyond its demonstrated improvement of diagnostic yield. \nLearning objectives: \n\nIdentify clinical and ethical issues raised by genomic sequencing.\nDescribe the concept of clinical utility and how it is used to assess genomic sequencing.\nRecognize the dual role of clinicians involved in genomic sequencing and its implications for patient care.\nReflect on the implications of secondary findings in practice\, in particular their actionability in children.\nConsider patient/parent expectations about genomic sequencing.\n\nSpeaker:\nDr. Anne-Marie Laberge \nBio \nDr. Laberge is a Medical Geneticist and Head of the Division of Medical Genetics at CHU Ste-Justine\, Clinical Full Professor in the Department of Pediatrics\, Faculty of Medicine\, and Department of Social and Preventive Medicine at the School of Public Health at Université de Montréal. Dr Laberge completed a residency in Medical Genetics at Université de Montréal\, an MPH and a PhD in Public Health Genetics\, both at the University of Washington. Dr Laberge was president of the Quebec Medical Geneticists Association for 5 years and is currently Chair of the Quebec Advisory Committee on Newborn Screening\, of the Quebec Molecular Diagnosis Network Incidental Findings Working Group and of the newly formed Quebec Central Ethics Committee on Medically Assisted Reproduction. Dr Laberge’s research focuses on the utility of genetic tests in practice and how genetic information influences patient management and patient/families’ decision-making. \nFriday\, October 20\, 2023\nFriday\, November 17\, 2023\nFriday\, December 15\, 2023\nFriday\, January 19\, 2024\nFriday\, February 16\, 2024\nFriday\, March 15\, 2024\nFriday\, April 19\, 2024\nFriday\, May 17\, 2024\nFriday\, June 21\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-2024-06-21/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240531T120000
DTEND;TZID=America/Toronto:20240531T130000
DTSTAMP:20260626T175756
CREATED:20230927T144256Z
LAST-MODIFIED:20240527T133756Z
UID:10000039-1717156800-1717160400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nNew \nAs of March 2024\, the Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada. \nNote\, to obtain credit for this CPD activity\, you must keep track of the seminars attended.  An easy way to do this is to download and save the certificate for each seminar attended which is available through the evaluation link sent after the seminar to attendees.  A letter at the end of the year will NOT be sent. \n \n  \n  \nTitle: Development of Gene Therapy for GM2 Gangliosidosis and Creatine Deficiency Disorders \nIt is all about developing gene therapies for genetic conditions. \nLearning objectives: \n\nDefine ‘Gene Therapy’.\nList at least three factors affecting gene therapy outcomes.\nList at least three conditions that can be treated by gene therapy- approved products.\nList at least three ethical issues with gene therapy.\n\n \n  \nSpeaker: Dr. Jagdeep Walia \nBio \nDr. Jagdeep Walia is a medical geneticist and full-time professor in the Division of Medical Genetics\, Department of Pediatrics. A medical school graduate from India\, he finished his residency in Medical Genetics from University of Manitoba and then joined Queen’s University in 2012 as a clinical Geneticist. \nDr. Walia’s research lab focuses on developing novel gene therapy approaches for inherited and acquired neurodegenerative disorders. His focus is on GM2 gangliosidoses\, creatine deficiency disorders\, galactosemia and 2 rare autism spectrum disorders. The translational nature of this work is exemplified by the initiation of a phase 1/2 clinical trial for infantile GM2 gangliosidoses at Queen’s University/Kingston Health Sciences Centre using adeno-associated virus vector (AAV) as a tool for gene transfer to the central and peripheral nervous system. He has published more than 50 peer-reviewed articles and has been invited as a speaker on the topic of gene therapy for local\, national and international conferences. \nFriday\, September 29\, 2023\nFriday\, October 27\, 2023\nFriday\, November 24\, 2023\nFriday\, December 15\, 2023 @ 12:30pm – 1:30pm ET\nFriday\, January 26\, 2024\nFriday\, February 23\, 2024\nFriday\, March 22\, 2024\nFriday\, April 26\, 2024\nFriday\, May 31\, 2024\nFriday\, June 28\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-2024-05-24/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240517T110000
DTEND;TZID=America/Toronto:20240517T120000
DTSTAMP:20260626T175756
CREATED:20230927T144938Z
LAST-MODIFIED:20240415T151742Z
UID:10000025-1715943600-1715947200@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \n \n  \n  \nFriday\, October 20\, 2023\nFriday\, November 17\, 2023\nFriday\, December 15\, 2023\nFriday\, January 19\, 2024\nFriday\, February 16\, 2024\nFriday\, March 15\, 2024\nFriday\, April 19\, 2024\nFriday\, May 17\, 2024\nFriday\, June 21\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/%tribe_events_slug%/telegraf-2024-05-17/2024-05-17/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240426T120000
DTEND;TZID=America/Toronto:20240426T130000
DTSTAMP:20260626T175756
CREATED:20240425T172107Z
LAST-MODIFIED:20240425T172804Z
UID:10000022-1714132800-1714136400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nNew \nAs of March 2024\, the Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada. \nNote\, to obtain credit for this CPD activity\, you must keep track of the seminars attended.  An easy way to do this is to download and save the certificate for each seminar attended which is available through the evaluation link sent after the seminar to attendees.  A letter at the end of the year will NOT be sent. \nThe Cardiac Genome Clinic: Using the Genome to Enhance Care for Patients and Families with Heart Disease \nAn overview of the Ted Rogers Cardiac Genome Clinic’s activities in providing personalized care for patients with congenital heart disease\, cardiomyopathy\, arrhythmia\, and aortopathies. \nLearning objectives: \n\nUnderstand the current yield and utility of short-read WGS in congenital heart disease (CHD).\nLearn how NOTCH1 diagnosis is changing the care of CHD.\nHighlight EIF3 as an example of gene discovery in CHD.\n\nSpeaker – Dr. Rebekah Jobling  \nDr. Jobling completed her medical training at the University of Calgary. She completed both her residency in Medical Genetics and Genomics and her Canadian College of Medical Genetics training in Molecular Laboratory genetics at the Hospital for Sick Children. Currently she works as a Clinical and Laboratory geneticist at SickKids. She has been a Principal Investigator in the Ted Rogers Cardiac Genome Clinic since 2018. \n  \n \n  \n  \nFriday\, September 29\, 2023\nFriday\, October 27\, 2023\nFriday\, November 24\, 2023\nFriday\, December 15\, 2023 @ 12:30pm – 1:30pm ET\nFriday\, January 26\, 2024\nFriday\, February 23\, 2024\nFriday\, March 22\, 2024\nFriday\, April 26\, 2024\nFriday\, May 31\, 2024\nFriday\, June 28\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-2/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240419T110000
DTEND;TZID=America/Toronto:20240419T120000
DTSTAMP:20260626T175756
CREATED:20230927T144938Z
LAST-MODIFIED:20240415T185514Z
UID:10000026-1713524400-1713528000@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \n \n  \n  \nConsiderations for Developing\, Testing\, and Administering Genetic Therapies \nGenetic therapies like gene replacement therapy and antisense oligonucleotides (ASOs) are increasingly asked about in the clinic by patients and families. We will review specific examples of commercially available and bespoke/precision/”n-of-1″ treatments\, and discuss considerations related to the design\, testing\, and implementation of genetic therapies for rare genetic diseases. \nLearning objectives: \n\nIdentify approved genetic therapies for rare genetic diseases.\nCompare different strategies for DNA and RNA based treatments.\nDescribe considerations that are relevant to patient and family counselling.\n\nSpeaker:\nDr. Gregory Costain \nBio\nGreg Costain is a medical geneticist and physician-scientist at SickKids\, and co-leads the Advanced Therapeutics Node of the SickKids Precision Child Health initiative. \n  \nFriday\, October 20\, 2023\nFriday\, November 17\, 2023\nFriday\, December 15\, 2023\nFriday\, January 19\, 2024\nFriday\, February 16\, 2024\nFriday\, March 15\, 2024\nFriday\, April 19\, 2024\nFriday\, May 17\, 2024\nFriday\, June 21\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-2024-04-19/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240328T110000
DTEND;TZID=America/Toronto:20240328T120000
DTSTAMP:20260626T175756
CREATED:20230927T144938Z
LAST-MODIFIED:20240325T200300Z
UID:10000027-1711623600-1711627200@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \n \n  \n  \nInclusion of Molecular Genetics in Newborn Screening \nThis presentation will provide a quick review of NBS in Ontario and where molecular genetics is being used. The goal is to understand some of the techniques and logistics associated with molecular genetic in NBS at present\, and to examine some of the opportunities and challenges associated with molecular genetics in NBS. \nLearning objectives: \n– Examine some of the opportunities and challenges associated with molecular genetics in NBS.\n– Understand some of the techniques and logistics associated with molecular genetic in NBS at present. \nSpeaker: \nDr. Kristin Kernohan \nKristin Kernohan\, Laboratory Head of Molecular Genetics Laboratory\, completed her HB.Sc\, Honours specialization in Genetics and Ph.D in Biochemistry at the University of Western Ontario. After graduate school she completed a post-doctoral fellowship with Care4Rare and CCMG training at the Children’s Hospital of Eastern Ontario before joining NSO in 2018. Dr. Kernohan is certified by the Canadian College of Medical Geneticists. Her research interests include the identification of new disease genes and developmental of new technologies for molecular diagnostics. \n  \nFriday\, October 20\, 2023\nFriday\, November 17\, 2023\nFriday\, December 15\, 2023\nFriday\, January 19\, 2024\nFriday\, February 16\, 2024\nFriday\, March 28\, 2024\nFriday\, April 19\, 2024\nFriday\, May 17\, 2024\nFriday\, June 21\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-2024-03-15/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240322T120000
DTEND;TZID=America/Toronto:20240322T130000
DTSTAMP:20260626T175756
CREATED:20230927T144256Z
LAST-MODIFIED:20240402T175721Z
UID:10000038-1711108800-1711112400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nNew \nAs of March 2024\, the Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada. \nNote\, to obtain credit for this CPD activity\, you must keep track of the seminars attended.  An easy way to do this is to download and save the certificate for each seminar attended which is available through the evaluation link sent after the seminar to attendees.  A letter at the end of the year will NOT be sent. \n \n  \n  \nGenetic Medicine For Rare Neurogenetic Disease \nIn this presentation\, I will summarize the current state of the field of genetic medicine approaches for neurogenetic disease. I will focus on gene therapy\, and talk about its advantages and challenges. \nLearning objectives: \n\nIdentify the benefits and challenges of gene therapy for neurogenetic disease.\nAssess the emerging genetic medicine approaches for treating neurogenetic conditions.\n\nSpeaker:\nDr. Jim Dowling \nBio \nDr. Jim Dowling is a staff clinician and senior scientist at the Hospital for Sick Children and a Professor of Paediatrics and Molecular Genetics at the University of Toronto. He is also the Mogford Campbell Family Chair of Paediatric Neuroscience. Dr. Dowling received his BSc and MSc from Yale University\, his MD/PhD from the University of Chicago\, and did his residency in child neurology at Children’s Hospital of Philadelphia. \nDr. Dowling’s clinical expertise is in childhood neurogenetic disorders. His research examines questions of disease pathogenesis and therapy development for congenital muscle diseases. In addition to his research program\, he currently serves as board chair of TREAT NMD\, as an executive board member of the World Muscle Society\, and as the pediatric lead of the NMD4C pan-Canadian neuromuscular network. He was recently honored to receive the Researcher of the Year Award from Muscular Dystrophy Canada. \nFriday\, September 29\, 2023\nFriday\, October 27\, 2023 – cancelled\nFriday\, November 24\, 2023\nFriday\, December 15\, 2023 @ 12:30pm – 1:30pm ET\nFriday\, January 26\, 2024\nFriday\, February 23\, 2024\nFriday\, March 22\, 2024\nFriday\, April 26\, 2024\nFriday\, May 31\, 2024\nFriday\, June 28\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-2024-03-22/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240223T120000
DTEND;TZID=America/Toronto:20240223T130000
DTSTAMP:20260626T175756
CREATED:20230927T144256Z
LAST-MODIFIED:20240220T175337Z
UID:10000037-1708689600-1708693200@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \n \n  \n  \nTitle: A Clinician’s Guide to Preimplantation Genetic Testing \nWe aim to introduce the concepts of preimplantation genetic testing\, including for aneuploidy\, structural rearrangements\, and monogenic disorders. We will outline potential benefits\, limitations\, and risks associated with preimplantation genetic testing and demonstrate clinical utility through case examples. \nLearning objectives: \n\nIdentify the potential benefits and limitations of preimplantation genetic testing technology.\nDistinguish between the types of preimplantation genetic testing and eligibility criteria for each.\nConsider patient populations who would benefit from preimplantation genetic testing to integrate into clinical practice.\n\nSpeakers: \nTami Uster \nTami Uster is Canadian and American Board Certified Genetic Counsellor with Mount Sinai Hospital’s Prenatal Diagnosis and Medical Genetics Program and Mount Sinai Fertility. Tami graduated from the Genetic Counselling graduate program at Wayne State University in 2005 and has a specialty in prenatal diagnosis and infertility. \nEmma Blanche \nEmma Blanche (she/her) works as a board-certified genetic counsellor at Mount Sinai Fertility. She graduated from the Masters of Genetic Counselling program at Wayne State University in 2022. \nFriday\, September 29\, 2023\nFriday\, October 27\, 2023 – cancelled\nFriday\, November 24\, 2023\nFriday\, December 15\, 2023 @ 12:30pm – 1:30pm ET\nFriday\, January 26\, 2024\nFriday\, February 23\, 2024\nFriday\, March 22\, 2024\nFriday\, April 26\, 2024\nFriday\, May 31\, 2024\nFriday\, June 28\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-2024-02-23/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240216T110000
DTEND;TZID=America/Toronto:20240216T120000
DTSTAMP:20260626T175756
CREATED:20230927T144938Z
LAST-MODIFIED:20240209T150638Z
UID:10000028-1708081200-1708084800@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \n \n  \n  \nTitle: Portrait of Rare Hereditary Diseases in the French-Canadian Founder Population of Saguenay-Lac-Saint-Jean \nThe population of the Saguenay-Lac-Saint-Jean (SLSJ) region\, located in the province of Quebec\, Canada\, is recognized as a founder population\, where some rare autosomal recessive diseases show a high prevalence. Through the clinical and molecular study of 82 affected individuals from 60 families\, this study outlines 12 diseases identified as recurrent in SLSJ. Their carrier frequency was estimated with the contribution of 1059 healthy individuals\, increasing the number of autosomal recessive diseases with known carrier frequency in this region from 14 to 25. We review the main clinical and molecular features previously reported for these disorders. Five of the studied diseases have a potential lethal effect and three are associated with intellectual deficiency. Therefore\, we believe that the provincial program for carrier screening should be extended to include these eight disorders. The high-carrier frequency\, together with the absence of consanguinity in most of these unrelated families\, suggest a founder effect and genetic drift for the 12 recurrent variants. We recommend further studies to validate this hypothesis\, as well as to extend the present study to other regions in the province of Quebec\, since some of these disorders could also be present in other French-Canadian families. \nLearning objectives: \n\nDescribe the clinical and molecular characteristics of hereditary diseases that are recurrent in the Saguenay-Lac-Saint-Jean region of Quebec.\nIllustrate the carrier frequency of these diseases in saguenay-Lac-Saint-Jean.\nRecognize the role of provincial screening strategies in the prevention of these\nconditions.\n\n \n  \n  \n  \nSpeaker:\nDr. Tania Cruz-Marino \nBio \nDr. Tania Cruz Marino received her medical degree in Cuba from Holguin Medical University. She completed the Medical Genetics residency program as well as her PhD studies at the Havana Superior Institute of Medical Sciences. Dr Cruz Marino headed the Predictive Diagnosis Department at the Cuban national center for research and rehabilitation of hereditary ataxias. She has authored or co-authored 38 articles published in peer-reviewed journals. \nDr. Cruz Marino holds a specialist certificate in Medical Genetics granted by the Collège des Médecins du Québec. Being the first full-time medical geneticist in the Saguenay\, she has contributed to the development of the Medical Genetics Service in that region. She is an assistant professor at the Human Genetics Department (MUHC)\, a member of the Medical Genetics Division and the Specialized Medicine Department at the MUHC\, and she has a particular interest in Cancer Genetics. \nFriday\, February 16\, 2024\nFriday\, March 28\, 2024\nFriday\, April 19\, 2024\nFriday\, May 17\, 2024\nFriday\, June 21\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-2024-02-16/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240126T120000
DTEND;TZID=America/Toronto:20240126T130000
DTSTAMP:20260626T175756
CREATED:20230927T144256Z
LAST-MODIFIED:20240119T175405Z
UID:10000036-1706270400-1706274000@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \n \n  \n  \nTitle: Novel Outcome Measures For Genomic Medicine \nThis presentation will describe a framework for outcome measurement in genomic medicine\, highlighting the complexities associated with defining the notion of value in this context. Since the value of genomic testing depends upon perspective and clinical context\, this presentation will summarize ongoing work to develop and validate novel measures of utility from clinician and patient perspectives. \nLearning objectives: \n\nDescribe a multi-dimensional framework for outcome measurement in genomic medicine.\nUnderstand a methodological approach for developing and validating outcome measures.\nConsider the application of novel outcome measures for a range of clinical genetics settings.\n\nSpeaker: Dr. Robin Hayeems \nBio \nDr. Robin Hayeems is a Senior Scientist in Child Health Evaluative Sciences (CHES) at The Hospital for Sick Children (SickKids) and an Associate Professor in the Institute of Health Policy\, Management and Evaluation (IHPME) at the University of Toronto. She is trained in genetic counselling (ScM\, Johns Hopkins University)\, public health and bioethics (PhD\, University of Toronto)\, health policy research (University of Toronto\, IHPME Postdoctoral Fellowship) and health services research (University of Toronto\, Institute for Clinical and Evaluative Sciences Postdoctoral Fellowship).Using applied health services and policy research methods\, Robin’s work focuses on the delivery\, evaluation\, and governance of genomic screening and diagnostic tools in the prenatal\, newborn\, and early childhood periods. As a member of several provincial advisory committees\, her work informs and is informed by policy development in this area. Robin holds a Canada Research Chair (Tier 2) in Genomics and Health Policy. \nFriday\, September 29\, 2023\nFriday\, October 27\, 2023 – cancelled\nFriday\, November 24\, 2023\nFriday\, December 15\, 2023 @ 12:30pm – 1:30pm ET\nFriday\, January 26\, 2024\nFriday\, February 23\, 2024\nFriday\, March 22\, 2024\nFriday\, April 26\, 2024\nFriday\, May 31\, 2024\nFriday\, June 28\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-2024-01-26/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240112T110000
DTEND;TZID=America/Toronto:20240112T120000
DTSTAMP:20260626T175756
CREATED:20230927T144938Z
LAST-MODIFIED:20240109T164936Z
UID:10000029-1705057200-1705060800@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \n \n  \n  \nTitle: Monogenic Autoinflammatory Disease: An Overview \nThis talk will provide an overview of monogenic autoinflammatory disease and given the learner a mechanism to group these disorders by pathology. We will discuss genetic testing strategies and the importance of diagnosis to help manage therapeutic options. \nLearning Objectives: \n\nDescribe the main features of several monogenic autoinflammatory disorders.\nRecommend a genetic testing strategy for a patient presenting with autoinflammatory symptoms.\n\nSpeaker: Dr. Ashish Marwaha \nBio \nAshish (Ash) Marwaha is an early career clinician scientist and clinical medical geneticist focusing on complex immune dysregulation disorders. He has used a collaborative approach to build an integrated research care pathway that aims to diagnose the cause of rare diseases and lead to improved targeted treatment. His research expertise includes whole genome sequencing\, RNA sequencing\, polygenic risk score analysis\, epigenomics and machine learning integration of multi-omic data. He ultimately wants to use his extensive clinical trial experience to implement precision therapy for this patient population. \n  \nFriday\, October 20\, 2023\nFriday\, November 17\, 2023\nFriday\, December 15\, 2023\nFriday\, January 12\, 2024 (date changed)\nFriday\, February 16\, 2024\nFriday\, March 15\, 2024 (date may change)\nFriday\, April 19\, 2024\nFriday\, May 17\, 2024\nFriday\, June 21\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-2024-01-19/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20231215T123000
DTEND;TZID=America/Toronto:20231215T133000
DTSTAMP:20260626T175756
CREATED:20230927T144256Z
LAST-MODIFIED:20231211T173533Z
UID:10000035-1702643400-1702647000@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \n \n  \n  \nTitle: Discerning Diversity: The Role of Data in Advancing Health Equity from a Genetics Perspective \nIn this presentation\, we will explore how we can leverage sociodemographic data to advance health equity. We will unpack the challenges related to the ethical collection\, use and interpretation of data for use in equity initiatives. We will also propose actionable strategies for addressing disparities and building inclusive clinical genetics health services. \nLearning objectives: \n\nDefine and distinguish between race\, ethnicity\, ancestry and other identifiers used in data collection and reporting.\nEvaluate the impact of race-based data collection on clinical decision-making.\nUnderstand different strategies to support appropriate use of data from equity-seeking communities.\n\nSpeaker: Muna Aden \nBio \nMuna Aden is a dedicated public health professional with thirteen years of experience in health equity research. She currently serves as the Equity Lead for the Provincial Genetics Program at Ontario Health. She earned an undergraduate degree from McMaster University in Health Studies and Psychology and holds a Master of Public Health from the University of Waterloo. She previously held the position of Research Officer at the University of Toronto where she coordinated Indigenous health equity research studies. She is passionate about knowledge exchange and advancing health equity and has collaborated with community leaders\, health care providers and policymakers to implement evidence-based interventions for equity-deserving communities. \nMuna regularly engages in capacity sharing initiatives and strives for the greater representation and meaningful involvement of community members in policy development. \nFriday\, September 29\, 2023\nFriday\, October 27\, 2023\nFriday\, November 24\, 2023\nFriday\, December 15\, 2023 @ 12:30pm – 1:30pm ET\nFriday\, January 26\, 2024\nFriday\, February 23\, 2024\nFriday\, March 22\, 2024\nFriday\, April 26\, 2024\nFriday\, May 31\, 2024\nFriday\, June 28\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-2023-12-22/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20231215T110000
DTEND;TZID=America/Toronto:20231215T120000
DTSTAMP:20260626T175756
CREATED:20230927T144938Z
LAST-MODIFIED:20231211T173105Z
UID:10000030-1702638000-1702641600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \n \n  \n  \nTitle: Exome Sequencing in Prenatal Diagnosis: Benefits and Pitfalls \nThis presentation will review the evidence supporting the use of prenatal exome sequencing in the context of a fetal abnormality detected on ultrasound. In addition\, the challenges of using exome sequencing in the prenatal setting will be reviewed. Cases will be presented to illustrate the learning objectives. \nLearning objectives: \n\nCite the evidence supporting a role of exome sequencing in prenatal diagnosis.\nDescribe the limitations of exome sequencing when used in the prenatal setting.\n\nSpeaker: Dr. Sylvie Langlois \nBio \nDr. Sylvie Langlois is a clinical and molecular geneticist with a special interest in prenatal genetics. She is a Professor in the Department of Medical Genetics at UBC and co-director of the Residency Training program with Dr. Kate Blood. Her research has focused on the implementation of new technologies in the prenatal field including cell free DNA screening and exome sequencing. \nFriday\, October 20\, 2023\nFriday\, November 17\, 2023\nFriday\, December 15\, 2023\nFriday\, January 19\, 2024\nFriday\, February 16\, 2024\nFriday\, March 15\, 2024\nFriday\, April 19\, 2024\nFriday\, May 17\, 2024\nFriday\, June 21\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-2023-12-15/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20231124T120000
DTEND;TZID=America/Toronto:20231124T130000
DTSTAMP:20260626T175756
CREATED:20230927T144256Z
LAST-MODIFIED:20231123T185801Z
UID:10000034-1700827200-1700830800@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \n \n  \n  \nRedevelopment Work in BC’s Provincial Medical Genetics Program \nThe presentation will focus on features of the Handra et al.\, (2023) publication. This will be contextualized in discussions of our program’s redevelopment work\, which aims to improve our internal program\, its resources\, and our collaborations. \nLearning objectives: \n\nConsider an initiative to refresh and grow a province’s clinical genomics capacity.\nDescribe use of process mapping and an electronic QI platform.\nDiscuss use of articulating explicit principles\, frameworks\, policies\, evaluation.\nReflect on progresses and what we envision next in our redevelopment initiative\, with attention on how our program is similar and different to others in Canada\, with goals of building program identity/shared vision and resources within the program\, as well as engage and enable other (potential) contributors to genomics care.\n\nSpeaker:\nDr. Linlea Armstrong \n \nBio\nDr. Linlea Armstrong is a medical geneticist and currently medical director for BC’s Provincial Medical Genetics Program. Dr. Armstrong maintains a general medical genetics practice\, with special interests in the application of next generation sequencing to rare disease care\, as well as in the diagnosis of pediatric tumour and cancer predisposition\, and differences of sexual development. One of the most exciting parts of the medical directorship has been her program’s collaboration with the lab in setting up our Genome Sequencing BC service. Dr. Armstrong has a passion for medical education and quality improvement\, and over time has served in leadership roles with UBC’s Medical Genetics and Genomics Royal College residency program\, Masters of Genetic Counselling program\, and Vancouver Fraser Medical Program’s Faculty Development team. \n  \nFriday\, September 29\, 2023\nFriday\, October 27\, 2023 – cancelled\nFriday\, November 24\, 2023\nFriday\, December 15\, 2023 @ 12:30pm – 1:30pm ET\nFriday\, January 26\, 2024\nFriday\, February 23\, 2024\nFriday\, March 22\, 2024\nFriday\, April 26\, 2024\nFriday\, May 31\, 2024\nFriday\, June 28\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-2023-11-24/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20231117T110000
DTEND;TZID=America/Toronto:20231117T120000
DTSTAMP:20260626T175756
CREATED:20230927T144938Z
LAST-MODIFIED:20231106T184625Z
UID:10000041-1700218800-1700222400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf (cancelled)
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \n \n  \n  \nFriday\, October 20\, 2023\nFriday\, November 17\, 2023\nFriday\, December 15\, 2023\nFriday\, January 19\, 2024\nFriday\, February 16\, 2024\nFriday\, March 15\, 2024\nFriday\, April 19\, 2024\nFriday\, May 17\, 2024\nFriday\, June 21\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-2023-11-17/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20231027T120000
DTEND;TZID=America/Toronto:20231027T130000
DTSTAMP:20260626T175756
CREATED:20230927T144256Z
LAST-MODIFIED:20231016T150753Z
UID:10000033-1698408000-1698411600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series (cancelled)
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \n  \nFriday\, September 29\, 2023\nFriday\, October 27\, 2023 – cancelled\nFriday\, November 24\, 2023\nFriday\, December 15\, 2023 @ 12:30pm – 1:30pm ET\nFriday\, January 26\, 2024\nFriday\, February 23\, 2024\nFriday\, March 22\, 2024\nFriday\, April 26\, 2024\nFriday\, May 31\, 2024\nFriday\, June 28\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-2023-10-27/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20231020T110000
DTEND;TZID=America/Toronto:20231020T120000
DTSTAMP:20260626T175756
CREATED:20230927T144938Z
LAST-MODIFIED:20231016T214259Z
UID:10000021-1697799600-1697803200@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf (cancelled)
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \n \n  \n  \nFriday\, October 20\, 2023\nFriday\, November 17\, 2023\nFriday\, December 15\, 2023\nFriday\, January 19\, 2024\nFriday\, February 16\, 2024\nFriday\, March 15\, 2024\nFriday\, April 19\, 2024\nFriday\, May 17\, 2024\nFriday\, June 21\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230929T120000
DTEND;TZID=America/Toronto:20230929T130000
DTSTAMP:20260626T175756
CREATED:20230927T144256Z
LAST-MODIFIED:20240402T175757Z
UID:10000032-1695988800-1695992400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nNew \nAs of March 2024\, the Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada. \nNote\, to obtain credit for this CPD activity\, you must keep track of the seminars attended.  An easy way to do this is to download and save the certificate for each seminar attended which is available through the evaluation link sent after the seminar to attendees.  A letter at the end of the year will NOT be sent. \n \n  \n  \nFriday\, September 29\, 2023\nFriday\, October 27\, 2023 – cancelled\nFriday\, November 24\, 2023\nFriday\, December 15\, 2023 @ 12:30pm – 1:30pm ET\nFriday\, January 26\, 2024\nFriday\, February 23\, 2024\nFriday\, March 22\, 2024\nFriday\, April 26\, 2024\nFriday\, May 31\, 2024\nFriday\, June 28\, 2024
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230630T120000
DTEND;TZID=America/Toronto:20230630T130000
DTSTAMP:20260626T175756
CREATED:20220902T211051Z
LAST-MODIFIED:20230626T144431Z
UID:10000016-1688126400-1688130000@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG - The Leading Strand Series June 2023
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nClick HERE to register. \nCCMG Position Statement: Genetic And Metabolic Investigations For Patients With Neurodevelopmental Disorders \nThe co-chairs of the CCMG working group to develop a guideline for genetic and metabolic investigations for patients with NDDs will discuss the process and results. A national multidisciplinary working group developed a position statement for the genetic and metabolic investigation of patients with neurodevelopmental disorders (NDDs). The impetus for this guideline\, the methodology and process for its development and key recommendations will be presented. \nLearning Objectives: \n\nUnderstand the impetus for a Canadian guideline for genetic and metabolic investigation of neurodevelopmental disorders (NDDs)\nDescribe and apply methodologies for guideline development\nPlan an investigation for patients with neurodevelopmental disorders\n\nSpeakers \nDr. Melissa Carter\nDr. Hilary Vallance \nBios \n \n  \nDr. Melissa Carter is a clinical geneticist at CHEO in Ottawa\, specializing in neurodevelopmental disorders. She completed her residency in Ottawa and then a fellowship in developmental pediatrics in Toronto. She is the co-chair of a CCMG working group to develop guidelines for etiological investigations for patients with neurodevelopmental disorders\, and is currently the Clinical Lead of the Neurodevelopmental Genetics expert group at Ontario Health. \n  \n \n  \nDr. Hilary Vallance is a Medical Biochemist / Biochemical Geneticist at BC Children’s Hospital who obtained her MD from the University of British Columbia (UBC). She completed a residency in Medical Biochemistry at UBC followed by fellowship training in Biochemical Genetics. She is the Director of the BC Newborn Screening Program. Her research contributions have been in the area of inborn errors of metabolism and newborn screening for treatable conditions. \n  \nDates \nSeptember 23\nOctober 28\nNovember 25\nDecember 16\nJanuary 27\nFebruary 24\nMarch 31\nApril 28\nMay 26\nJune 30 \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-june-2023/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230607T130000
DTEND;TZID=America/Toronto:20230607T150000
DTSTAMP:20260626T175756
CREATED:20230512T153558Z
LAST-MODIFIED:20230512T154429Z
UID:10000031-1686142800-1686150000@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:CCMG-CCGM 2023 Annual General Meeting
DESCRIPTION:The 2023 Annual General Meeting of the CCMG-CCGM Members will be Wednesday\, June 7 from 1:00 – 3:00 PM ET. \nRegistration is required and is open to members in good standing. View the 2023 AGM page to view the documents and to register. You must be logged in to view this page. \nThe meeting will be held on the zoom platform.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/ccmg-ccgm-2023-annual-general-meeting/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230526T120000
DTEND;TZID=America/Toronto:20230526T130000
DTSTAMP:20260626T175756
CREATED:20220902T210950Z
LAST-MODIFIED:20230512T155842Z
UID:10000015-1685102400-1685106000@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG - The Leading Strand Series May 2023
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nThe Health Impact Of Founder Mutations In The French Canadian Population Of Quebec: A Historical Perspective \nWe will review the demographic history of the European settlement of Quebec. We will discuss the major regional differences in settlement histories. We will demonstrate how demographic and historical factors have influenced the differential frequencies of genetic conditions in Quebec in particular of neurogenetic diseases. \nLearning objective: \nConsider the impact of shared genetic heritage on the different regional frequencies of genetic diseases in Quebec. \nSpeaker: Dr. Bernard Brais \nBio \nBernard Brais MD MPhil PhD is a neurogeneticist and historian of medicine\, Professor of Neurology and Genetics at McGill University and Director of the Rare Neurological Diseases group of the Montreal Neurological Institute. His research largely focuses on the genetic basis of rare neuromuscular disorders with founder effects in Quebec. He has played an leading role in the identification of the first mutations in the genes responsible for Oculopharyngeal Muscular Dystrophy (OPMD\, PABPN1)\, Hereditary Sensory and Sensory Neuropathy type 2A (HSAN2A\, WNK1)\, Limb girdle muscular dystrophy Recessive 12 (LGMDR12\, ANO5)\, Hypomyelinating Leukodystrophy types 7 and 8 (HLD7 and HLD8\, POLR3A and POLR3B)\, Dominant NAGLU neuropathy\, congenital core ZAK myopathy and FGF14/SCA27B GAA repeat expansion in late ataxias. \nDates \nSeptember 23\nOctober 28\nNovember 25\nDecember 16\nJanuary 27\nFebruary 24\nMarch 31\nApril 28\nMay 26\nJune 30 \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-may-2023/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230519T110000
DTEND;TZID=America/Toronto:20230519T120000
DTSTAMP:20260626T175756
CREATED:20220902T205324Z
LAST-MODIFIED:20230505T200541Z
UID:10000007-1684494000-1684497600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf May 2023
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nMedical Genetics And Choosing Wisely Canada\nDr. Tyler Peikes \nThe Choosing Wisely movement has grown tremendously internationally across all disciplines in medicine\, as well as nursing and allied health. Choosing Wisely Canada launched in 2014 and has since fostered dialogue at the level of national clinician societies to inform individual practitioners as well as shape policy. CCMG has been actively involved since 2015\, initially publishing a list of “5 tests and treatments to question.” This list was recently updated with 7 additional recommendations. This presentation will introduce trainees to Choosing Wisely and then review the Medical Genetics recommendations in depth to frame experiences in training and direct further learning. \nLearning Objectives \n\nReflect on the “Choosing Wisely” movement and philosophy.\nDescribe the consensus-building approach to successful collaboration.\nReview the 12 recommendations\, rationales and evidence.\nApply the recommendations to practice and further learning.\n\nBio\nDr. Peikes is a practicing medical geneticist and healthcare ethics consultant in Winnipeg\, Manitoba. He graduated from Queen’s University with a B.A.(honours) in Philosophy. He completed his M.D. at the University of Manitoba and M.A.(Bioethics and Health Policy) at Loyola University Chicago. He serves as a member of the University of Manitoba Health Research Ethics Board and is the director of the Clinical Ethics Service for the main tertiary care hospital complex in Winnipeg. \nDr. Peikes joined the Ethics\, Education and Public Policy (E2P2) CCMG committee in 2019 and has served as the Choosing Wisely Canada representative since then. \nDates \nSeptember 16 – UBC\nOctober 14 – TBD\nNovember 18 – TBD\nDecember 16 – Ottawa\nJanuary 20 – Calgary\nFebruary 17 – McGill\nMarch 17 – TBD\nApril 14 – Toronto\nMay 19 – Manitoba\nJune 16 – Montreal \nClick HERE to register. \n 
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-may-2023/
CATEGORIES:TeleGraf
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230428T120000
DTEND;TZID=America/Toronto:20230428T130000
DTSTAMP:20260626T175756
CREATED:20220902T210851Z
LAST-MODIFIED:20230420T213232Z
UID:10000014-1682683200-1682686800@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG - The Leading Strand Series April 2023
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nTandem DNA Repeat Expands our Understanding of Complex Disorders  \nObjectives: \n\nIdentify tandem repeat expansions from short-read genome sequence data.\nAssess the contribution of tandem repeat expansions in complex disorders.\nConsider analyzing tandem repeats in other genetic disorders.\n\nDescription:\nIdentification of genetic risk factors has provided important information on understanding the functional pathways involved in many of complex disorders. However\, the contributing genetic factors identified in many complex disorders so far generally confer less risk than expected from the empirical estimates of their heritability. Tandem DNA repeats make up around 6% of the human genome and have been associated with more than 50 monogenic disorders\, but their involvement in complex disorders is largely unknown. I will present our novel approach to detect genome-wide tandem repeat expansions. This approach has led to the identification of rare tandem repeat expansions contributing to autism spectrum disorder and other conditions. It provides a model to search for missing heritability in other complex disorders. \n \nSpeaker:\nDr. Ryan Yuen \nBio \nDr. Ryan Yuen is a Senior Scientist in Genetics & Genome Biology Program at The Hospital for Sick Children\, and an Assistant Professor in Department of Molecular Genetics at the University of Toronto. His research focuses on exploiting whole genomescanning methodologies to dissect the underlying genetic architecture in complex disorders. \nDates \nSeptember 23\nOctober 28\nNovember 25\nDecember 16\nJanuary 27\nFebruary 24\nMarch 31\nApril 28\nMay 26\nJune 30 \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-april-2023/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230421T110000
DTEND;TZID=America/Toronto:20230421T120000
DTSTAMP:20260626T175756
CREATED:20220902T205223Z
LAST-MODIFIED:20230418T151731Z
UID:10000006-1682074800-1682078400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf April 2023
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nGenetics of Premature Ovarian Insufficiency\nThis presentation will provide a clinical overview of Premature Ovarian Insufficiency (POI) including diagnosis and management. It will include case-based examples and will discuss the growing area of monogenic causes of POI\, beyond FMR1 and chromosomal abnormalities. \nObjectives: \n\nIdentify the clinical presentations of premature ovarian insufficiency.\nIdentify hallmark features of monogeic causes of premature ovarian insufficiency.\nDevelop an approach to the diagnosis and management premature ovarian insufficiency including monogenic causes.\n\nSpeaker – Dr. Ari Morgenthau\nDr. Morgenthau is an Endocrinologist based in Toronto\, Canada\, with an interest in endocrine genetics. He currently is a Clinical and Metabolics Genetics Fellow at the University of Toronto. Dr. Morgenthau is also one of the co-founders of the Rare Compassion Program\, an initiative that provides medical students with a unique opportunity to gain firsthand exposure to rare and genetics disorders. \nDr. Morgenthau’s educational background includes a Bachelor of Science degree from Toronto Metropolitan University\, a Master of Science degree from the University of Calgary\, and an MD from New York Medical College. He completed his core Internal Medicine training at Dalhousie University and his Adult Endocrinology and Metabolism training at the University of Toronto. \n  \nDates \nSeptember 16 – UBC\nOctober 14 – TBD\nNovember 18 – TBD\nDecember 16 – Ottawa\nJanuary 20 – Calgary\nFebruary 17 – McGill\nMarch 17 – TBD\nApril 21 – Toronto\nMay 19 – Manitoba\nJune 16 – Montreal \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-april-2023/
CATEGORIES:TeleGraf
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230331T120000
DTEND;TZID=America/Toronto:20230331T130000
DTSTAMP:20260626T175756
CREATED:20220902T210752Z
LAST-MODIFIED:20230329T153119Z
UID:10000013-1680264000-1680267600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG - The Leading Strand Series March 2023
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nGenetic Test Interpretation from Pathogenicity to Variant Function\nDr. Las will present approaches to interpret clinical genetic tests of patients with neurodevelopmental disorders and epilepsy\, while considering variant pathogenicity and function.\nObjectives: \n\nIdentify the current status of genetics in neurodevelopmental disorders.\nAssess the use of genetic testing.\nConsider patient selection for precision medicine trials.\n\nSpeaker – Dr. Dennis Lal\nBio\nThe Lal Research Group focuses on the discovery\, evaluation\, and translation of biomarker into clinical care. Specifically\, we aim to develop computational methods which integrate large genetic\, clinical\, and biological data sets to improve the prediction of patient outcomes – paving the way for personalized medicine. \nDennis is Assistant Professor in the Department of Molecular Medicine in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (CCLCM) and Assistant Staff in the Genomic Medicine Institute with a secondary staff appointment in the Neurological Institute’s Epilepsy Center both Cleveland\, US. In addition to his primary appointments in Cleveland\, he is Visiting Scientist at the Broad Institute of Harvard and M.I.T.\, Cambridge\, US as well as Group Leader at the Cologne Center for Genomics\, Cologne\, Germany. \nDates \nSeptember 23\nOctober 28\nNovember 25\nDecember 16\nJanuary 27\nFebruary 24\nMarch 31\nApril 28\nMay 26\nJune 30 \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-march-2023/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230324T120000
DTEND;TZID=America/Toronto:20230324T130000
DTSTAMP:20260626T175756
CREATED:20221202T193938Z
LAST-MODIFIED:20230301T200909Z
UID:10000020-1679659200-1679662800@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:CCMG Webinar - Presented by Illumina
DESCRIPTION:Detection Of Gene Fusions As Drivers For Targeted Therapies Using Rna Based Comprehensive Genomic Profiling (cgp) \nPresented by Illumina \nDescription:\nGenomic alterations known as gene fusions often drive cancer and can be important to detect across many different tumor types. Today\, targeted therapies exist for a growing number of gene fusions and have proven to be effective and safe options for patients. However\, variation in testing technologies can result in significant differences in the likelihood of fusion identification. In this session we will review the clinical actionability of known and novel driver fusions across tumor types and discuss the role of a CGP approach utilizing both DNA and RNA sequencing to accurately identify all targetable gene fusions. \nSpeaker: Erica Schnettler \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/ccmg-webinar-presented-by-illumina/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230317T110000
DTEND;TZID=America/Toronto:20230317T120000
DTSTAMP:20260626T175756
CREATED:20220902T205123Z
LAST-MODIFIED:20230310T144241Z
UID:10000005-1679050800-1679054400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf March 2023
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nTitle: Approach To Mucopolysaccharidoses\nStarting with the biochemistry of glycosaminoglycans\, we will review the pathophysiology of mucopolysaccharidoses. Attendees will learn to distinguish between the various subtypes based on their clinical presentations and diagnostic test results. At the end\, we will compare the various treatment modalities available as well as strategies for the development of future treatments. \nLearning Objectives \n\n\n\n\n\n\n\nDescribe the general pathophysiology of mucopolysaccharidoses.\nDistinguish between the different subtypes of mucopolysaccharidoses.\nCompare the different treatment modalities/strategies for managing.\n\n\n\n\n\n\n\nSpeaker bio\nDr. Andrea Yu is currently a metabolic physician working at CHEO and an assistant professor at the University of Ottawa. She completed her residency in Medical Genetics and Genomics as well as her Clinical Biochemical Fellowship at the University of Ottawa. From 2018 – 2020\, she was a Clinical Geneticist and Assistant Professor at the London Health Sciences Centre/University of Western Ontario. Her academic interests include medical education and research in describing rare inborn errors of metabolism. \n  \nClick HERE to register. \n  \n  \n  \nDates \nSeptember 16 – UBC\nOctober 14 – TBD\nNovember 18 – TBD\nDecember 16 – Ottawa\nJanuary 20 – Calgary\nFebruary 17 – McGill\nMarch 17 – TBD\nApril 14 – Toronto\nMay 19 – Manitoba\nJune 16 – Montreal \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-march-2023/
CATEGORIES:TeleGraf
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
END:VCALENDAR